相关实验视频

Updated: Jan 9, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

[CAR-T细胞疗法的概述:放射科医生应该知道什么]

Mirjam Gerwing¹, Michel Eisenblätter²

¹Universitätsinstitut für Diagnostische und Interventionelle Radiologie, Med. Fakultät und Universitätsklinikum OWL, Klinikum Lippe, Universität Bielefeld, Röntgenstraße 18, 32756, Detmold, Deutschland. Mirjam.Gerwing@klinikum-lippe.de.

Radiologie (Heidelberg, Germany)

|December 9, 2025

概括

化学抗原受体T细胞 (CAR-T) 治疗是一种复杂的免疫疗法. 放射科医生必须了解CAR-T原理,以评估治疗反应,并检测瘤患者的副作用.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
放射学放射学是一门学科.

背景情况:

德国的瘤中心越来越多地提供CAR-T细胞疗法.
进步和补充疗法伴随着CAR-T治疗.
对于放射科医生来说,熟悉这些发展是非常重要的.

研究的目的:

为放射科医生提供关于CAR-T细胞治疗的信息.
突出评估治疗反应的重要性.
强调早期检测潜在的副作用.

主要方法:

对血液瘤疾病的标准治疗方法的审查.
专注于与补充免疫疗法结合的CAR-T细胞疗法.
使用截面成像 (PET/CT) 进行分期和反应评估.

主要成果:

卡特-T细胞疗法显示反应率约为66.4%.
最近CAR-T疗法的进展代表了瘤治疗的重大创新.
这种疗法标志着免疫治疗的新时代.

结论:

放射科医生需要对CAR-T细胞治疗原则有充分的了解.
准确评估治疗反应至关重要.
早期识别潜在的副作用对于患者管理至关重要.

关键词:

血液瘤性疾病血液瘤性疾病免疫治疗是一种免疫疗法.作用机制作用机制副作用副作用副作用副作用治疗反应治疗反应.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Published on: October 27, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.